Search results
PROMOTED
Stay up to date with the latest clinical evidence in transthyretin amyloid cardiomyopathy (ATTR-CM) with this video series spotlighting key cardiomyopathy updates presented at ESC Heart Failure Congress (HFA) 2026.In the first session, Dr Mathew Maurer (Columbia University, New York, US) takes a deep dive into the CARDIO-TTRansform data, exploring the current treatment landscape and ongoing unmet…
View more
Spotlight on HFA 2026: Updates on Cardiomyopathies
Author(s):
Mathew S Maurer
,
Margot K Davis
Added:
1 month ago
Video Series
Added:
10 months ago
Source:
Radcliffe Cardiology
According to European Society of Cardiology (ESC) guidelines, a systematic search for diagnostic clues, or ‘red flags’ (RFs), is recommended in patients with hypertrophic cardiomyopathy (HCM) to help tailor disease management. A new study published in the European Heart Journal has investigated the prevalence and clinical significance of these RFs across different HCM phenotypes and clinical…
View more
Mahadevappa Mahesh
Job title: Assistant Professor of Radiology
Author
Virginia Tsapaki
Job title: Chief of the Medical Physics Department
Author
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
1 year ago
Roberto Pini
Author
Valentina Colcelli
Author
Andrea Barucci
Author
Added:
5 months ago
Source:
Radcliffe Cardiology
Frailty is a common and significant factor associated with adverse outcomes in patients with heart failure, but the prognostic utility of simple assessment tools in contemporary practice remains an area of investigation. A new study using data from a large Japanese registry has found that the Clinical Frailty Scale (CFS) effectively captures both physical and cognitive decline and is an…
View more
Author(s):
Ambarish Pandey
Added:
1 month ago
HFA Congress 2026 — Dr Ambarish Pandey (University of Texas Southwestern Medical Center, Texas, US) joins us to discuss findings on diuretic resistance drawn from TRANSFORM-HF, a large-scale, pragmatic, randomised clinical effectiveness trial comparing torsemide versus furosemide in patients hospitalised with heart failure.TRANSFORM-HF enrolled 2,973 patients across 60 US sites, randomising 1:1…
View more
